Cancer gene prioritization by integrative analysis of mRNA expression and DNA copy number data: A comparative review

Briefings in Bioinformatics

Volumn 14, Issue 1, 2013, Pages 27-35

  Lahti, Leo ^a   Schäfer, Martin ^b   Klein, Hans Ulrich ^c   Bicciato, Silvio ^d   Dugas, Martin ^c  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b TU DORTMUND UNIVERSITY   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Algorithms; Cancer; Data integration; DNA copy number; Gene expression; Microarrays

Indexed keywords

DNA; MESSENGER RNA; RNA;

ALGORITHM; BIOLOGY; BIOSYNTHESIS; COMPARATIVE STUDY; COPY NUMBER VARIATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; HUMAN; METHODOLOGY; NEOPLASM; ONCOGENE; REVIEW;

ALGORITHMS; COMPUTATIONAL BIOLOGY; DNA COPY NUMBER VARIATIONS; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; HUMANS; NEOPLASMS; ONCOGENES; RNA, MESSENGER; RNA, NEOPLASM;

EID: 84869381476     PISSN: 14675463     EISSN: 14774054     Source Type: Journal    
DOI: 10.1093/bib/bbs005     Document Type: Review

References (60)

1. Chin L, Gray J. Translating insights from the cancer genome into clinical practice. Nature 2008;452:553-63.
2. Hawkins R, Hon G, Ren B. Next-generation genomics: an integrative approach. Nat RevGenet 2010;11:476-86.
3. Berger J, Hautaniemi S, Mitra S, etal. Jointly analyzing gene expression and copy number data in breast cancer using data reduction models. IEEE/ACM Tr Comp Biol Bioinf 2006;3: 2-16.
4. Shen R, Olshen A, Ladanyi M. Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis. Bioinformatics 2009;25:2906-12.
5. Witten D, Tibshirani R. Extensions of sparse canonical correlation analysis, with applications to genomic data. Stat Appl GenetMol Biol 2009;8:28.
6. The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455:1061-68.
7. Leukemia Gene Atlas. www.leukemia-gene-atlas.org (15 December 2011, date last accessed).
8. Huang N, Shah PK, Li C. Lessons from a decade of integrating cancer copy number alterations with gene expression profiles. Brief Bioinformatics. Advance Access published on 23 September 2011, doi:10.1093/bib/bbr056.
9. De S, Babu M. Genomic neighborhood and the regulation of gene expression. Curr Opin Cell Biol 2010;22:7.
10. Lee H, Kong S, Park P. Integrative analysis reveals the direct and indirect interactions between DNA copy number aberrations and gene expression changes. Bioinformatics 2008; 24:889-96.
11. Phillips J, Hayward S, Wang Y, et al. The Consequences of chromosomal aneuploidy on gene expression profiles in a Cell line model for prostate carcinogenesis. Cancer Res 2001; 61:8143-9.
12. Pollack J, Sorlie T, Perou C, etal. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci 2001;99:12963-8.
13. Hyman E, Kauraniemi P, Hautaniemi S, et al. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 2002;62:6240-5.
14. Gu W, Choi H, Ghosh D. Global associations between copy number and transcript mRNA microarray data: an empirical study. Cancer Informatics 2008;6:17-23.
15. Myllykangas S, Junnila S, Kokkola A, et al. Integrated gene copy number and expression microarray analysis of gastric cancer highlights potential target genes. Int J Cancer 2008; 123:817-25.
16. Ortiz-Estevez M, De Las Rivas J, Fontanillo C, et al. Segmentation of genomic and transcriptomic microarrays data reveals major correlation between DNA copy number aberrations and gene-loci expression. Genomics 2011;97:86-93.
17. Harvey R, Mullighan C, Wang X, et al. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood 2010;116: 4874-84.
18. Yuan Y, Rueda O, Curtis C, et al. Penalized regression elucidates aberration hotspots mediating subtype-specific transcriptional responses in breast cancer. Bioinformatics 2011;27:2679-85.
19. Bicciato S, Spinelli R, Zampieri M, et al. A computational procedure to identify significant overlap of differentially expressed and genomic imbalanced regions in cancer datasets. Nucleic Acids Res 2009;37:5057-70.
20. van Wieringen W, van de Wiel M. Nonparametric testing for DNA copy number induced differential mRNA gene expression. Biometrics 2009;65:19-29.
21. Salari K, Tibshirani R, Pollack J. DR-Integrator: a new analytic tool for integrating DNA copy number and gene expression data. Bioinformatics 2010;26:414-6.
22. van Wieringen W, Belien J, Vosse S, et al. ACE-it: a tool for genome-wide integration of gene dosage and RNA expression data. Bioinformatics 2006;22:1919-20.
23. Akavia U, Litvin O, Kim J. An integrated approach to uncover drivers of cancer. Cell 2010;143:1005-17.
24. Hautaniemi S, Ringnér M, Kauraniemi P, et al. A strategy for identifying putative causes of gene expression variation in human cancers. J Franklin Institute 2004;341:77-88.
25. Solvang H, Lingjaerde O, Frigessi A, et al. Linear and non-linear dependencies between copy number aberrations and mRNA expression reveal distinct molecular pathways in breast cancer. BMC Bioinformatics 2011;12:197.
26. Menezes R, Boetzer M, Sieswerda M, et al. Integrated analysis of DNA copy number and gene expression microarray analysis using gene sets. BMC Bioinformatics 2009;10: 203.
27. Peng J, Zhu J, Bergamaschi A, etal. Regularized multivariate regression for identifying master predictors with application to integrative genomics study of breast cancer. AnnApp Stat 2010;4:53-77.
28. Stranger B, Forrest M, Dunning M, et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007;315:848-53.
29. Schäfer M, Schwender H, Merk S, et al. Integrated analysis of copy number alterations and gene expression: a bivariate assessment of equally directed abnormalities. Bioinformatics 2009;25:3228-35.
30. Lipson D, Ben-Dor A, Dehan E, etal. Joint analysis of DNA copy numbers and gene expression levels. In: Jonassen I, Kim J, (eds). Proc Algorithms in Bioinformatics: 4th International WorkshopWABI 2004.Germany: Springer, 2004.
31. Soneson C, Lilljebjorn H, Fioretos T, et al. Integrative analysis of gene expression and copy number alterations using canonical correlation analysis. BMC Bioinformatics 2010;11: 191.
32. Parkhomenko E, Tritchler D, Beyene J. Sparse canonical correlation analysis with application to genomic data integration. Stat App GenetMol Biol 2009;8:1.
33. Waaijenborg C, Verselewel de Witt Hamer PC, Zwinderman AH. Quantifying the association between gene expressions and DNA-markers by penalized canonical correlation analysis. Stat Appl GenetMol Biol 2008;7:3.
34. Lahti L, Myllykangas S, Knuutila S, et al. Dependency detection with similarity constraints. Proc MLSP'09 IEEE InternationalWorkshop onMachine Learning for Signal Processing XIX. Piscataway, NJ, USA: IEEE, 2009;89-94.
35. Sheng J, Deng H, Calhoun V, et al. Integrated analysis of gene expression and copy number data on gene shaving using independent component analysis. IEEE Tr Comp Biol Bioinform 2011;8:1568-79.
36. Louhimo R, Hautaniemi S. CNAmet: an R package for integrating copy number, methylation and expression data. Bioinformatics 2011;27:887-8.
37. Haverty P, Fridlyand J, Li L, et al. High-resolution genomic and expression analyses of copy number alterations in breast tumors. Genes Chromosomes Cancer 2008;47:530-42.
38. Mullighan C, Goorha S, Radtke I, etal. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007;446:758-64.
39. Baasiri R, Glasser S, Steffen D, et al. The breast cancer gene database: a collaborative information resource. Oncogene 1999;18:7958-65.
40. Futreal P, Coin L, Marshall M, et al. A census of human cancer genes. Nat Rev Cancer 2004;4:177-83.
41. Mullighan C, Miller C, Radtke I, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 2008;453:110-4.
42. Bengtsson H, Wirapati P, Speed TP. A single-array preprocessing method for estimating full-resolution raw copy numbers from all Affymetrix genotyping arrays including GenomeWideSNP 5 & 6. Bioinformatics 2009;25:2149-56.
43. Bengtsson H, Irizarry R, Carvalho B, et al. Estimation and assessment of raw copy numbers at the single locus level. Bioinformatics 2008;24:759-67.
44. Olshen A, Venkatraman E, Lucito R, et al. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004;5:557-72.
45. Mullighan C, Su X, Zhang J, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009;360:470-80.
46. Lahti L, Elo LL, Aittokallio T, et al. Probabilistic analysis of probe reliability in differential gene expression studies with short oligonucleotide arrays. IEEE/ACM Tr Comp Biol Bioinform 2011;8:217-25.
47. Dai M, Wang P, Boyd A, et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 2005;33:e175.
48. Ferrari F, Solari A, Battaglia C, etal. PREDA: an R-package to identify regional variations in genomic data. Bioinformatics 2011;27:2446-7.
49. Aerts S, Lambrechts D, Maity S. Gene prioritization through genomic data fusion. Nat Biotech 2006;24:538-44.
50. de Bie T, Tranchevent L-C, van Oeffelen L, et al. Kernel-based data fusion for gene prioritization. Bioinformatics 2007;23:i125-32.
51. Kao C-F, Fang Y-S, Zhao Z, et al. Prioritization and evaluation of depression candidate genes by combining multidimensional data resources. PLoS One 2011;6:e18696.
52. Tranchevent L-C, Capdevila F, Nitsch D, et al. A guide to web tools to prioritize candidate genes. Brief Bioinform 2010; 12:22-32.
53. van Wieringen W, van de Wiel M, Ylstra B. Normalized, segmented or called aCGH data? Cancer Inform 2007;3: 321-7.
54. Lêcao K-A, González I, De'jean S. integrOmics: an R package to unravel relationships between two omics datasets. Bioinformatics 2009;25:2855-6.
55. Vaske C, Benz S, Sanborn J, et al. Inference of patient-specific pathway activities from multidimensional cancer genomics data using PARADIGM. Bioinformatics 2010;26:i237-45.
56. Witten D, Tibshirani R, Hastie T. A penalized matrix decomposition, with applications to sparse principal components and canonical correlation analysis. Biostatistics 2009;10: 515-34.
57. Andrews J, Kennette W, Pilon J. Multi-platform whole-genome microarray analyses refine the epigenetic signature of breast cancer metastasis with gene expression and copy number. PLoS One 2010;5:e8665.
58. Gaire R, Bailey J, Bearfoot J, et al. MIRAGAA-a methodology for finding coordinated effects of microRNA expression changes and genome aberrations in cancer. Bioinformatics 2010;26:161-7.
59. Qin L-X. An integrative analysis of microrna and mrna expression-a case study. Cancer Inform 2008;6:369-79.
60. Johnson N, Speirs V, Curtin N, etal. A comparative study of genome-wide SNP, CGH microrray and protein expression analysis to explore genotypic and phenotypic mechanisms of acquired antiestrogen resistance in breast cancer. Breast Cancer ResTreat 2008;111:55-63.